"Vaegra" supplement for impotence violates Viagra mark, Pfizer alleges.
This article was originally published in The Tan Sheet
Executive Summary
"VAEGRA" SUPPLEMENT IMPOTENCE TREATMENT EXPLOITS VIAGRA MARK for Pfizer's prescription erectile dysfunction treatment, the company charges in a suit filed April 20 in Atlanta federal court. The Vaegra name is being used by several entities marketing the dietary supplement as a treatment for impotence via direct mail, Pfizer maintains. The name Vaegra "was adopted by defendants with the intent to exploit the goodwill of Pfizer's Viagra trademark," the company says. Viagra (sildenafil), the first oral therapy for erectile dysfunction, was approved by FDA March 27.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning